CompletedPhase 4NCT05371262
Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism
Studying Congenital hypothyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federico II University
- Principal Investigator
- Mariacarolina Salerno, ProfessorFederico II University
- Intervention
- Levothyroxin(drug)
- Enrollment
- 72 enrolled
- Eligibility
- All sexes
- Timeline
- 2011 – 2018
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05371262 on ClinicalTrials.govOther trials for Congenital hypothyroidism
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07280104Infants With Primary Congenital Hypothyroidism and DevelopmentNigde Omer Halisdemir University
- RECRUITINGNANCT06864351Prospective Evaluation of OptiThyDoseUniversity Children's Hospital Basel
- ENROLLING BY INVITATIONNANCT06864039Quality of Life and Long-term Outcome of Adequately Treated Congenital HypothyroidismFederico II University
- RECRUITINGNCT06724224Comparison of Levothyroxine Formulations in the Treatment of Congenital HypothyroidismIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNCT05581147Thyroid Function and Structure in Klinefelter SyndromeUniversity of Roma La Sapienza